Merck & Co., Inc. (ETR:6MK)
86.30
-0.70 (-0.80%)
At close: Dec 5, 2025
Merck & Co. Revenue
Merck & Co. had revenue of $17.28B USD in the quarter ending September 30, 2025, with 3.72% growth. This brings the company's revenue in the last twelve months to $64.24B, up 1.68% year-over-year. In the year 2024, Merck & Co. had annual revenue of $64.17B with 6.74% growth.
Revenue (ttm)
$64.24B
Revenue Growth
+1.68%
P/S Ratio
3.89
Revenue / Employee
$856.47K
Employees
75,000
Market Cap
212.76B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 64.17B | 4.05B | 6.74% |
| Dec 31, 2023 | 60.12B | 832.00M | 1.40% |
| Dec 31, 2022 | 59.28B | 10.58B | 21.72% |
| Dec 31, 2021 | 48.70B | 7.19B | 17.31% |
| Dec 31, 2020 | 41.52B | 2.40B | 6.13% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Merck KGaA | 21.27B |
| Siemens Healthineers AG | 23.38B |
| Bayer Aktiengesellschaft | 45.87B |
| Fresenius SE & Co. KGaA | 22.45B |
| Sartorius Aktiengesellschaft | 3.52B |
| Fresenius Medical Care AG | 19.64B |
| Carl Zeiss Meditec AG | 2.18B |
| Fielmann Group AG | 2.42B |
Merck & Co. News
- 15 hours ago - Do These 3 Healthcare Stocks Need a Checkup? - The Motley Fool
- 17 hours ago - Vaccine makers raise concerns over US panel's shift away from hepatitis B shots for newborns - Reuters
- 19 hours ago - Is This Pharmaceutical Giant a Buy After a Major Acquisition? - The Motley Fool
- 1 day ago - These Are the 3 Hottest Stocks in the S&P 500 Heading Into the New Year. Should You Invest in Them? - The Motley Fool
- 1 day ago - Merck Unit Gets FDA Conditional Approval For EXZOLT CATTLE-CA1 To Treat Key Cattle Parasites - Nasdaq
- 1 day ago - Jim Cramer checks up on pharmaceutical company Merck - CNBC
- 1 day ago - After Hours Most Active for Dec 4, 2025 : AVPT, NVDA, CMCSA, INTC, KO, WMB, GM, DIS, MRK, AMZN, AAPL, BSX - Nasdaq
- 1 day ago - Merck & Co Inc at Citi Global Healthcare Conference Transcript - GuruFocus